John P. Kostrzewa

741 total citations
21 papers, 550 citations indexed

About

John P. Kostrzewa is a scholar working on Cellular and Molecular Neuroscience, Neurology and Surgery. According to data from OpenAlex, John P. Kostrzewa has authored 21 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 7 papers in Neurology and 4 papers in Surgery. Recurrent topics in John P. Kostrzewa's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). John P. Kostrzewa is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). John P. Kostrzewa collaborates with scholars based in United States, Poland and France. John P. Kostrzewa's co-authors include Richard M. Kostrzewa, Przemysław Nowak, R Brus, Ryszard Brus, Eben L. Rosenthal, William R. Carroll, Renée A. Desmond, Tim A. Iseli, William P. Lancaster and Jumin Sunde and has published in prestigious journals such as The Laryngoscope, Peptides and Amino Acids.

In The Last Decade

John P. Kostrzewa

21 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Kostrzewa United States 15 232 151 144 116 78 21 550
Antonio de la Fuente Spain 16 163 0.7× 190 1.3× 80 0.6× 17 0.1× 125 1.6× 35 600
Elena Zotova United States 13 177 0.8× 26 0.2× 49 0.3× 7 0.1× 184 2.4× 22 501
Xiangpan Kong China 11 56 0.2× 37 0.2× 27 0.2× 12 0.1× 103 1.3× 31 330
Kimberly A. McDowell United States 14 135 0.6× 12 0.1× 183 1.3× 19 0.2× 104 1.3× 22 480
Tatiana Brémovà-Ertl Germany 16 145 0.6× 20 0.1× 142 1.0× 17 0.1× 199 2.6× 37 764
David P. Bonislawski United States 8 257 1.1× 16 0.1× 123 0.9× 6 0.1× 283 3.6× 8 547
Alícia Costa Spain 13 116 0.5× 149 1.0× 18 0.1× 5 0.0× 225 2.9× 21 686
Bei Shao China 11 88 0.4× 19 0.1× 97 0.7× 9 0.1× 126 1.6× 12 467
Haruna Takeda Japan 10 37 0.2× 19 0.1× 31 0.2× 46 0.4× 86 1.1× 17 361
Shigeo Hirai Japan 11 262 1.1× 11 0.1× 555 3.9× 13 0.1× 126 1.6× 18 883

Countries citing papers authored by John P. Kostrzewa

Since Specialization
Citations

This map shows the geographic impact of John P. Kostrzewa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Kostrzewa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Kostrzewa more than expected).

Fields of papers citing papers by John P. Kostrzewa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Kostrzewa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Kostrzewa. The network helps show where John P. Kostrzewa may publish in the future.

Co-authorship network of co-authors of John P. Kostrzewa

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Kostrzewa. A scholar is included among the top collaborators of John P. Kostrzewa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Kostrzewa. John P. Kostrzewa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kostrzewa, John P. & Richard M. Kostrzewa. (2020). p-Chloroamphetamine-Enhanced Neostriatal Dopamine Exocytosis in Rats Neonatally Co-lesioned with 6-OHDA and 5,7-DHT: Relevance to Parkinson’s Disease. Neurotoxicity Research. 37(3). 543–552. 3 indexed citations
2.
Kostrzewa, John P., et al.. (2015). Perinatal 6-Hydroxydopamine Modeling of ADHD. Current topics in behavioral neurosciences. 29. 279–293. 12 indexed citations
4.
Kostrzewa, John P., et al.. (2015). Perinatal 6-Hydroxydopamine to Produce a Lifelong Model of Severe Parkinson’s Disease. Current topics in behavioral neurosciences. 29. 313–332. 15 indexed citations
5.
Kostrzewa, John P., Jumin Sunde, Kristen Riley, & Bradford A. Woodworth. (2010). Radiofrequency Coblation Decreases Blood Loss during Endoscopic Sinonasal and Skull Base Tumor Removal. ORL. 72(1). 38–43. 31 indexed citations
6.
Dean, Nichole R., Eben L. Rosenthal, William R. Carroll, et al.. (2010). Robotic-Assisted Surgery for Primary or Recurrent Oropharyngeal Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 136(4). 380–380. 56 indexed citations
7.
Kostrzewa, Richard M., et al.. (2010). Stereotypic Progressions in Psychotic Behavior. Neurotoxicity Research. 19(2). 243–252. 7 indexed citations
8.
Kostrzewa, John P., William P. Lancaster, Tim A. Iseli, et al.. (2009). Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. The Laryngoscope. 120(2). 267–272. 72 indexed citations
9.
Kostrzewa, Richard M., John P. Kostrzewa, Russell W. Brown, Przemysław Nowak, & Ryszard Brus. (2008). Dopamine receptor supersensitivity: Development, mechanisms, presentation, and clinical applicability. Neurotoxicity Research. 14(2-3). 121–128. 29 indexed citations
10.
Paris, Irmgard, Sergio Cárdenas, Carolina Perez-Pastene, et al.. (2008). The catecholaminergic RCSN-3 cell line: A model to study dopamine metabolism. Neurotoxicity Research. 13(3-4). 221–230. 16 indexed citations
11.
Kostrzewa, Richard M., et al.. (2007). Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment. Neurotoxicity Research. 11(1). 41–50. 37 indexed citations
12.
Kostrzewa, Richard M., et al.. (2007). Pharmacological models of ADHD. Journal of Neural Transmission. 115(2). 287–298. 40 indexed citations
14.
Kostrzewa, Richard M., et al.. (2005). Peculiarities of L-DOPA treatment of Parkinson?s disease. Amino Acids. 28(2). 157–164. 52 indexed citations
15.
Kostrzewa, Richard M., et al.. (2004). Dopamine D2 agonist priming in intact and dopamine-lesioned rats. Neurotoxicity Research. 6(6). 457–462. 24 indexed citations
16.
Brus, Ryszard, Richard M. Kostrzewa, Przemysław Nowak, Ken Perry, & John P. Kostrzewa. (2003). Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Neurotoxicity Research. 5(5). 329–338. 25 indexed citations
17.
Kostrzewa, Richard M., John P. Kostrzewa, & Ryszard Brus. (2003). Dopamine receptor supersensitivity: An outcome and index of neurotoxicity. Neurotoxicity Research. 5(1-2). 111–117. 18 indexed citations
18.
Kostrzewa, Richard M., John P. Kostrzewa, & R Brus. (2002). Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids. 23(1-3). 57–63. 56 indexed citations
19.
Kostrzewa, Richard M., John P. Kostrzewa, & R Brus. (2000). Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids. 19(1). 183–199. 23 indexed citations
20.
Kostrzewa, John P., et al.. (1976). [Diabetes insipidus and left-sided hemiplegia as a complication of early latent syphilis].. PubMed. 31(7). 285–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026